{
  "id": "HERDOO2_Rule_for_Discontinuing_Anticoagulation_in_Unprovoked_VTE.v0",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-04-24",
      "name": "Jack Msonkho",
      "organisation": "Cambio CDS",
      "email": "models@cambiocds.com"
    },
    "lifecycle_state": "Not set",
    "details": {
      "en": {
        "id": "en",
        "purpose": "Identifies low-risk women who can safely discontinue VTE treatment.",
        "keywords": [
          "Anticoagulation"
        ],
        "use": "Indefinite anticoagulation is burdensome and associated with bleeding risk. The HERDOO2 Rule can identify patients who have very low risk of recurrent VTE and can therefore safely stop anticoagulation in the short term.\n\nWhen to Use:\nWomen ≥18 years old with unprovoked VTE. Inclusion criteria in the original study:\n\nPatients diagnosed 5–7 months before enrollment.\nOn heparin or low molecular weight heparin (LMWH) for ≥5 days and oral anticoagulation for 5–7 months after the event.\nWithout recurrent VTE during the treatment period.\nNoncompressible segment on compression ultrasound of popliteal (or more proximal) leg vein, high-probability V/Q scan, or segmental (or larger) artery filling defect on spiral CT.\nExclusion criteria:\n\nLeg fracture.\nLower-extremity plaster cast.\nImmobilization for >3 days.\nGeneral anesthetic <3 months before index event.\nCancer diagnosis within 5 years.\n",
        "copyright": "@Cambio CDS"
      }
    },
    "other_details": {
      "references": "Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008;179(5):417-26.\n\nValidation\nRodger MA, Le gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017;356:j1065.\n\n"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "template_id": "openEHR-EHR-OBSERVATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          }
        }
      },
      "gt0007": {
        "id": "gt0007",
        "model_id": "openEHR-EHR-EVALUATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "template_id": "openEHR-EHR-EVALUATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/items[at0002]"
          }
        }
      },
      "gt0009": {
        "id": "gt0009",
        "model_id": "openEHR-EHR-OBSERVATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "template_id": "openEHR-EHR-OBSERVATION.herdoo2_rule_for_discontinuing_anticoagulation_in_unprovoked_vte.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          }
        }
      }
    },
    "rules": {
      "gt0011": {
        "id": "gt0011",
        "priority": 3,
        "when": [
          "$gt0003|Post-thrombotic signs|!=null",
          "$gt0004|D-dimer level|!=null",
          "$gt0005|Age, years|!=null",
          "$gt0006|BMI, kg/m²|!=null"
        ],
        "then": [
          "$gt0010|Total Score|.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 2,
        "when": [
          "$gt0010|Total Score|<=1"
        ],
        "then": [
          "$gt0008|Risk Group|=0|local::at0003|Low|"
        ]
      },
      "gt0013": {
        "id": "gt0013",
        "priority": 1,
        "when": [
          "$gt0010|Total Score|>1"
        ],
        "then": [
          "$gt0008|Risk Group|=1|local::at0004|Not Low|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE",
            "description": "HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE Identifies low-risk women who can safely discontinue VTE treatment."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Post-thrombotic signs",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "D-dimer level",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Age, years",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "BMI, kg/m²",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Risk Group",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Total Score",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Calculate Score"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Low Risk Group"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Not Low Risk Group"
          }
        }
      }
    }
  }
}